Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Basma Adeem Medical Co.SAU:9626 21 ROE % is 24.51% as of Dec. 2025, which is 8% below its 10-year median of 26.63. GuruFocus rates SAU:9626 with a GF Score™ of 21/100. The stock has 1 warning sign investors should review. Among 621 Healthcare Providers & Services companies, Basma Adeem Medical Co. ranks better than 87.28% on this metric.
The historical rank and industry rank for Basma Adeem Medical Co.'s ROE % or its related term are showing as below:
SAU:9626'
s ROE % Range Over the Past 10 Years
Min: 21.96 Med: 26.63 Max: 28.24
Current: 21.96
During the past 2 years, Basma Adeem Medical Co.'s highest ROE % was 28.24%. The lowest was 21.96%. And the median was 26.63%.
SAU:9626's ROE % is ranked better than 87.28% of 621
companies
in the Healthcare Providers & Services industry
Industry Median: 5.88
vs SAU:9626: 21.96
Basma Adeem Medical Co. (SAU:9626) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Basma Adeem Medical Co. ROE % Chart
Basma Adeem Medical Co. Annual Data
Trend
Dec24
Dec25
ROE %
28.24
25.02
Basma Adeem Medical Co. Semi-Annual Data
Jun24
Dec24
Jun25
Dec25
ROE %
0.00
35.11
16.05
24.51
SAU:9626 vs HCA, THC, DVA: ROE % Comparison
For the Medical Care Facilities subindustry, Basma Adeem Medical Co.'s ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Basma Adeem Medical Co. ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Basma Adeem Medical Co.'s ROE % distribution charts can be found below:
* The bar in red indicates where Basma Adeem Medical Co.'s ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Basma Adeem Medical Co. (SAU:9626) has a ROE % of 24.51% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Basma Adeem Medical Co. and its competitors. This is near median its historical median of 26.63. Over the past decade, Basma Adeem Medical Co.'s ROE % has ranged from 21.96 to 28.24. According to the industry distribution chart, Basma Adeem Medical Co. ranks #79 out of 621 companies in the Healthcare Providers & Services industry, placing it in the top 12.7%.
Is Basma Adeem Medical Co.'s ROE % too high?
Basma Adeem Medical Co.'s current ROE % of 24.51% is near median its 10-year median of 26.63. Over the past 10 years, this metric has ranged from a low of 21.96 to a high of 28.24. The Healthcare Providers & Services industry median ROE % is 5.88. Basma Adeem Medical Co.'s value of 24.51% is 316.8% above this industry median. Based on the distribution chart, Basma Adeem Medical Co. ranks #79 out of 621 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Basma Adeem Medical Co. has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Basma Adeem Medical Co.'s ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Basma Adeem Medical Co. ranks #79 out of 621 companies for ROE %. This places Basma Adeem Medical Co. in the top 13% of its industry — outperforming the majority of peers. The industry median ROE % is 5.88. Basma Adeem Medical Co.'s value of 24.51% is 316.8% above this benchmark. Historically, Basma Adeem Medical Co.'s own ROE % has ranged from 21.96 to 28.24 over the past decade. While the company's 10-year median is 26.63 vs. the industry median of 5.88, Basma Adeem Medical Co. has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.88, based on 621 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Basma Adeem Medical Co.'s current ROE % of 24.51% is 316.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Basma Adeem Medical Co. and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Basma Adeem Medical Co.'s current ROE % is 24.51%, which is near median its own 10-year median of 26.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Basma Adeem Medical Co. stock overvalued right now?
Basma Adeem Medical Co. (SAU:9626) has a current ROE % of 24.51%. The current ROE % is 24.51%, which is near median its 10-year median of 26.63 and 316.8% above the Healthcare Providers & Services industry median of 5.88. Basma Adeem Medical Co.'s overall GF Score™ is 21/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Basma Adeem Medical Co. (SAU:9626), the current ROE % is 24.51% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Basma Adeem Medical Co. operates in the field of dental medicine, treatment, and cosmetic dentistry. The company provides its services to clients through its professional and specialized medical staff in therapeutic and cosmetic dentistry.
21GF Score
Get the complete analysis for SAU:9626
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9626 has been successfully added to your 
